Quantum BioPharma Ltd. (CSE:QNTM)
Canada
· Delayed Price · Currency is CAD 11.75
+0.62 (5.57%)
Apr 1, 2025, 4:00 PM EST
Quantum BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -14.2 | -17.9 | -23.61 | -35.29 | -31.8 | Upgrade
|
| Depreciation & Amortization | 0.49 | 2.51 | 4.53 | 4.05 | 3.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.59 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 4.56 | - | - | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0 | 0.38 | 0.23 | 0.86 | 0.77 | Upgrade
|
| Stock-Based Compensation | 0.15 | 3.84 | 1.53 | 7.44 | 8.05 | Upgrade
|
| Other Operating Activities | -2.49 | -5.84 | -2.76 | 0.68 | -0.21 | Upgrade
|
| Change in Accounts Receivable | -0.15 | 0.16 | 0.22 | -0.11 | 0.44 | Upgrade
|
| Change in Inventory | -0.12 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 4.27 | 2.05 | -0.7 | 3.6 | 0.9 | Upgrade
|
| Change in Unearned Revenue | 1 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 4.75 | -0.57 | -6.64 | -0.61 | -0.53 | Upgrade
|
| Operating Cash Flow | -6.88 | -10.83 | -28.33 | -20.75 | -19.13 | Upgrade
|
| Capital Expenditures | -1 | - | -0.11 | - | - | Upgrade
|
| Cash Acquisitions | - | 0.03 | - | 0.77 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.25 | -0.5 | - | Upgrade
|
| Investment in Securities | -0.5 | -0.3 | -0.24 | - | 6.48 | Upgrade
|
| Other Investing Activities | - | - | 12.73 | - | 0.04 | Upgrade
|
| Investing Cash Flow | -1.5 | -0.27 | 12.12 | 0.27 | 6.51 | Upgrade
|
| Long-Term Debt Issued | 1.01 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.07 | -0.95 | Upgrade
|
| Long-Term Debt Repaid | -0.06 | -0.19 | -0.14 | -0.06 | -0.04 | Upgrade
|
| Total Debt Repaid | -0.06 | -0.19 | -0.14 | -0.13 | -0.99 | Upgrade
|
| Net Debt Issued (Repaid) | 0.95 | -0.19 | -0.14 | -0.13 | -0.99 | Upgrade
|
| Issuance of Common Stock | 10.67 | 0.02 | - | 38.34 | 25.16 | Upgrade
|
| Repurchase of Common Stock | - | -2.96 | -1.93 | - | - | Upgrade
|
| Financing Cash Flow | 11.62 | -3.13 | -2.07 | 38.21 | 24.17 | Upgrade
|
| Net Cash Flow | 3.24 | -14.22 | -18.28 | 17.73 | 11.56 | Upgrade
|
| Free Cash Flow | -7.88 | -10.83 | -28.45 | -20.75 | -19.13 | Upgrade
|
| Free Cash Flow Per Share | -6.93 | -17.78 | -47.74 | -38.59 | -103.25 | Upgrade
|
| Levered Free Cash Flow | -6.06 | -15.51 | -2.75 | -8.19 | -13.8 | Upgrade
|
| Unlevered Free Cash Flow | -6.04 | -15.51 | -2.72 | -8.15 | -13.65 | Upgrade
|
| Change in Net Working Capital | -4.5 | 9.83 | -8.72 | -1.95 | 6.95 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.